Close Menu
Business Voice NowBusiness Voice Now
    Facebook X (Twitter) Instagram
    Business Voice NowBusiness Voice Now
    Subscribe
    • Markets
      • IPO
      • Market News
    • Business
      • FMCG
      • Retail
      • Quick Commerce
      • Startups
    • Healthcare
    • Technology
    • Energy
    • Voices
      • Entrepreneur – CXO Stories
      • Corporate Office story
    • E Magazine
      • Year 2026
        • October 2026
        • September 2026
        • August 2026
        • July 2026
    Business Voice NowBusiness Voice Now
    Home»Business»Akums Drugs receives EU GMP approval for two Haridwar-based manufacturing plants
    Business

    Akums Drugs receives EU GMP approval for two Haridwar-based manufacturing plants

    By July 11, 2022No Comments4 Mins Read
    Share Facebook Twitter Pinterest LinkedIn Tumblr Email
    Follow Us
    Google News Flipboard Threads
    Share
    Facebook Twitter LinkedIn Pinterest Email
    Read Time:3 Minute, 36 Second

    Akums Drugs & Pharmaceuticals Ltd. has recently received European Union GMP approval for two of their manufacturing units in Haridwar.

    New Delhi (India), July 11: Akums Drugs & Pharmaceuticals Ltd., the leading contract manufacturing pharmaceutical company in India, has recently acquired the stringent European Union (EU) GMP  approval for two of their manufacturing units in Haridwar. Following this prestigious nod, the gateway for several new opportunities in the European and other stringent regulatory markets is open to Akums Drugs. This move is another assent to Akums’ “Quality First” approach to work, which has now been endorsed by the EU -GMP beside all top-notch Indian and multinational pharmaceutical companies, who are already Akums’ long-standing partners.

    Akums has received EU GMP approval for its two manufacturing plants. One plant manufactures solid oral dosage forms such as tablets, hard gelatin capsules, powders in sachets, etc. belonging to the general category, and Another plant manufactures large volume parenteral and small volume parenterals lines, including vials, ampoules, eyedrops, FFS  as well as for dry powder injections in the penicillin line.

    Founder, Promoter and Director, Akums Drugs & Pharmaceuticals, Shri Sandeep Jain, says, “We are happy to announce that Akums Drugs has received EU GMP approval for two of our Haridwar-based manufacturing facilities, thus paving the path for new opportunities from the entire European Union as well as many other regulatory markets. We are already the largest Indian contract manufacturing company, manufacturing > 12% of country’s domestic supply, but what makes us happiest is being recognised for our “Quality First” approach. While we have been endorsed for this quality by our partners, who are also leading Indian and multinational pharmaceutical companies, the latest one from the EU GMP is very widely recognised & accepted. Congratulations to the entire team, and I hope this is the beginning of numerous possibilities for us.”

    Founder, Promoter and Director Akums Drugs & Pharmaceuticals, Shri Sanjeev Jain, says, “Akums is already exporting to over 50 countries worldwide. With the esteemed EU GMP nod, we have now gained access to the most stringent global pharmaceutical markets besides the USA. These include the entire European Union, other markets like South Africa, Canada, Malaysia, Indonesia, Thailand, Australia/New Zealand and most middle-eastern countries. Since the EU GMP is their gold standard, we are welcome to cater to the pharmaceutical demands of all these geographies. With a large R&D infrastructure already in place, we are well equipped with a good basket of Products in our pipeline to expand our presence in these regulated markets. While we are extremely proud and excited to expand our presence in these markets, the Indian domestic market has always been our pride & passion and will continue to be so. The trust our partners have in us, and our Quality is paramount for us. ”

    Akums Drugs & Pharmaceuticals Ltd. is India’s largest contract manufacturing pharmaceutical company, manufacturing more than 12% of India’s consumption. The organisation deals in manufacturing and exporting formulations in a broad spectrum of dosage forms & therapeutic segments. The company currently supplies to almost all Indian and multinational pharmaceutical companies across the globe and is the 67th largest employer in the country. The ten state-of-the-art facilities are dedicated to oral solid dosage forms (with separate units for beta lactum and non-beta lactum formulations), Oral liquid dosage forms, Sterile dosage forms (injectable, eye, ear & nasal), hormonal (oral and injectable), ointments & cosmetics, personal care,  Ayurvedic, food supplements & nutraceuticals and animal health care.

    In a few years, the organisation has become the icon of the Indian pharmaceutical manufacturing industry and currently manufactures more than 12% of the country’s total medicinal requirements. With creme-de-la-creme of dedicated pharmaceutical personnel and standardised practices, Akums has been successful in attaining national and international accreditations and building trust-based on efficacy, safety & quality. The organisation is certified with WHO-GMP, ISO 9001:2015, ISO 14001:2015 certificates and various international accreditations, like; ANVISA, Brazil, NAFDAC, Nigeria, FDB, Ghana, PMPB, Malawi, amongst others and exports to 53 countries across the world.

    If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

    About Post Author


    RNT Reporter


    dhaval.rntoday@gmail.com

    https://republicnewstoday.com

    The post Akums Drugs receives EU GMP approval for two Haridwar-based manufacturing plants appeared first on Republic News Today.

    Business
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

    Related Posts

    What NoBrokerHood Takes Care of During the Diwali Chaos While Residents Have a Seamless Experience

    October 15, 2026

    COLORFUL Launches the iGame X870E VULCAN W OC Motherboard

    October 15, 2026

    Akta Wealth Launches Akta Flexicap Fund to Deepen Its Capital Management Offering

    October 15, 2026

    Comments are closed.

    Recent Post
    • What NoBrokerHood Takes Care of During the Diwali Chaos While Residents Have a Seamless Experience
    • IMF backs India’s GDP growth calculation amid controversy over the 7.8% economic growth for the April to June quarter of FY 2026-27
    • COLORFUL Launches the iGame X870E VULCAN W OC Motherboard
    • Akta Wealth Launches Akta Flexicap Fund to Deepen Its Capital Management Offering
    • Aniket Nikam’s Nyay Vishwas Foundation Bridges the Justice Gap for Rural Communities in Maharashtra
    • Led by Ex-Angry Birds Executive, Xtendr Launches bitom, a Platform Bringing New Dimensions to Brand Engagement and Licensing
    • Poondla Siddharth Reddy: Building a Mentor Economy Through the Power of Donated Time
    • KORA by NM Welcomes Aditya Roy Kapur as Its New Brand Face

    Type above and press Enter to search. Press Esc to cancel.